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Abstract
Background: Paratuberculosis vaccination has been in use in some regions for many decades, but
results have not been widely spread. A new Mycobacterium avium subsp. paratuberculosis (MAP)
killed vaccine was studied in relationship with its effects on fecal shedding and milk production in
four farms while other two were kept as controls submitted to a test and cull scheme.
Findings: Fecal detection (n = 1829) and milking records (n = 2413) have been analyzed after two
(5 herds) and four (1 herd) years of the beginning of the intervention. Shedder prevalence was
reduced by 100% in three of the four vaccinated farms, 68% in the total of vaccinated animals and
46% in the two control farms. Total amount of MAP shed was reduced 77% in the vaccinated farms
and 94% in the control farms. Overall milk production increased up to 3.9% after vaccination, while
there was no significant difference in production after intervention in the non-vaccinated farms.
Conclusion: MAP shedding reduction can be quickly accomplished both by vaccination and by
testing and culling. However, vaccination appears to be a less expensive and more sustainable
strategy since it required one single intervention and was also associated with an increase in milk
production.
Background
Paratuberculosis or Johne's disease eradication programs
based on the detection and culling of infected animals
(testing and culling, T&C) have been relatively unsuccess-
ful due to the low sensitivity of diagnostic tests and
unending expenses for detection of infection in individual
animals. Even though vaccination has been successfully
used for over 30 years in the US and in the UK as well as
in other countries, scientific reports on its efficacy are old
and scarce in spite of having shown to yield higher bene-
fit/cost ratios than T&C strategies [1,2].
Near eradication of bovine tuberculosis in the Basque
Country, as well as high prevalence of clinical cases of
paratuberculosis in some farms, led the local Animal
Health Authorities to support a vaccination trial in farms
with a history of heavy clinical incidence. This trial was
implemented as a field assay to test the efficacy of a new
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paratuberculosis vaccine specifically designed for use in
cattle and that is based in whole cell heat-killed MAP (Sil-
irum®, CZ Veterinaria, S.A., Porriño, Spain) in an oil adju-
vant. The objective of the present report is to evaluate its
performance on MAP fecal excretion as an indicator of
epidemiologic efficacy, to assess any possible therapeutic
effects of vaccination and to estimate direct benefits in
milk production that could facilitate the spread of this
control strategy by encouraging farmers to use of the vac-
cination as a control strategy at their own expense. The
follow up is scheduled to last five years in each herd, and
therefore the results presented here are a preliminary
assessment.
Findings
MAP detection in feces
Fecal shedding frequencies by PCR and by isolation
before intervention and at each annual sampling are
shown in table 1 and figure 1. Significant reduction in
fecal shedding across herds ranged from 71% to 90% with
PCR, and from 75% to 100% with culture. Globally, vac-
cination seemed to induce greater reductions (86% and
68% for PCR and culture, respectively) than T&C (60%
and 46% for PCR and culture, respectively. This relation-
ship seemed to be inverted when the amounts of shedding
were compared (Figure 2). For this variable, T&C
(4,702,381 CFU/day/100 cows to 292,308 CFU/day/100
cows) yielded a reduction of 94% versus a 76% associated
to vaccination (1,925,926 CFU/day/100 cows to 452,675
CFU/day/100 cows) (Figure 2).
Milk production
A total of 2762 lactations, of which 2413 were complete
305-day standard lactations (SL), were used for the analy-
sis of variance. The overall model including parity, strat-
egy (testing and culling or vaccination) and intervention
(ante- and post-intervention) and all their interactions
was highly significant on standard and real lactation milk
production, days of lactation and average daily produc-
tion (ADP). Only the models for SL and ADP as depend-
ent variables had an R2 value greater than 0.10 and thus
only these were retained for the final analysis (Table 2).
The SL model, with an R2 value of 0.1792, showed that the
strongest effects were those of parity and strategy (p <
Prevalence of cows excreting MAP in their feces at each fecal control as measured by isolation and by IS900 PCR Figure 1
Prevalence of cows excreting MAP in their feces at each fecal control as measured by isolation and by IS900 
PCR. AI0: Before intervention, PI1: First post-intervention control; PI2: Second control post-intervention. Culture T&C: 
Results of fecal culture in the two herds without vaccination. Culture VAC: Results of fecal culture in the four herds with vac-
cination. PCR T&C: Fecal IS900 PCR positive results in the two herds without vaccination. PCR VAC: Fecal IS900 PCR positive 
results in the four herds with vaccination.
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0.0001) and the interaction between strategy and inter-
vention (p = 0.0259). Upon marginal means comparison,
it appeared that there was no significant difference
between ante- and post-intervention SL in the T&C herds
(-186.87 kg; p = 0.2318), while there was a difference of
257.13 kg in the vaccinated ones (p = 0.0376) (Table 2).
No other effect or interaction had a p value below 0.10.
Regarding the ADP, the only significant effects were again
those of the strategy and parity interaction between strat-
egy and ante- or post-intervention periods (p = 0.0035).
The differences between ante- and post-intervention ADP
were -0.54 kg (p = 0.2079) and 1.08 kg (p = 0.0020)
respectively for T&C and vaccination. The latter accounted
for a difference of 329.4 kg in SL. The cows in the T&C
strategy showed higher variability in the differences in
production, with a significant decrease (p = 0.0336 SL; p
= 0.0030 ADP) for the second calving. The vaccinated
herds showed always a positive balance between ante- and
post-intervention milking records, with significant
increases in production for first (p = 0.0759, N.S. SL; p =
0.0247 ADP) and third (p = 0.0422; p = 0.2627, N.S.)
calving.
Discussion
The results presented here show that both T&C and vacci-
nation had a significant effect on the bacteriologic varia-
bles relevant to the epidemiology of paratuberculosis.
Even though the timing and magnitude of the reductions
were not the same in all the farms, the overall effect in
terms of frequency of shedders and of estimated amount
of bacteria excreted were greatly reduced both by T&C and
by vaccination. It is somewhat surprising that so good
results were observed in such a short period of time. These
observations are in agreement with most works on paratu-
berculosis vaccination [3-15].
Regarding milk production, in this study, vaccination per-
formed better than T&C. This is in agreement with reports
on paratuberculosis related milk losses [1,16] even
though in a study vaccination had a slight negative effect
Evolution of estimated amount of daily bacterial shedding per cow according to the strategy Figure 2
Evolution of estimated amount of daily bacterial shedding per cow according to the strategy. Although in the first 
years T&C appears to be substantially more efficient, vaccination still seems to reduce shedding by three fourths. AI0: before 
intervention, PI1: First post-intervention control; PI2: Second control post-intervention; Reduction: Percent of reduction in the 
estimated amount of bacteria shed from the initial to the last control. Notice that this approach shows a slower reduction with 
vaccination than when only frequency of shedders is considered.
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on non-infected animals that was compensated by the
large effects on milk production of advanced cases of
paratuberculosis[9].
An important issue in this study is that the controls have
not been taken from matched individuals in the same
herd, but that each farm has been on one strategy. This
was a difficult decision taken at the beginning of the study
in order to avoid the influence of treatment on one group
affecting the other in the long period of follow up
imposed by the slow infection characteristic of paratuber-
culosis. This, in addition to the need of farmers of an
immediate and readily visible solution to their paratuber-
culosis problem, as well as the management difficulties of
herds with mixed strategies, made it more advisable to use
a before-/after- comparison strategy in spite of its limita-
tions in order to attribute the effects solely to vaccination.
Our results, obtained in over 80% of cases from animals
vaccinated after at least three months of life in its infected
farm, show that there might be therapeutic effects related
to the pathogenesis-modifying effects of vaccination that
were already observed twenty years go by Benedictus et
al[5]. This implies that vaccination could not only provide
an immediate relief to farms affected by a heavy incidence
of paratuberculosis, but would allow to foresee a com-
pletely new strategy for treatment of human IBD if its
paratuberculosis etiology is demonstrated and accepted
by the gastroenterological community.
In conclusion, the results presented here show that similar
levels of paratuberculosis control can be achieved in a
short period of time both by T&C and by vaccinating with
the new killed vaccine, at least in some farms. If eradica-
tion is ruled out as the failure of long term strategies
shows[17,18], vaccination stands out as the most eco-
Table 1: Frequency of fecal shedding at different time point as detected by IS900 PCR and isolation and rate of reduction between pre-
intervention sampling and last control.
IS900-PCR AI0 PI1 PI2 PI4
Herd n % n % n % n % Herd shedding reduction P Strategy reduction p
T&C HER 196 7.65 195 4.62 182 2.20 - 71.1% 0.0126 60.4% 0.0039
URI 144 9.72 176 9.09 143 4.90 - 49.6% 0.0890
AGE 76 17.11 76 2.63 79 2.53 - 85.2% 0.0019
VAC END 0 - 0 - 64 3.13 71 0.0 100.0%* 0.2229
SAG 46 32.56 48 0.00 34 5.88 - 81.9% 0.0036 85.8% <0.0001
SAL 63 15.87 60 20.00 65 1.54 - 90.3% 0.0037
MAP isolation AI0 PI1 PI2 PI4
H e r d n%n%n % Herd shedding reduction P Strategy reduction P
T&C HER 193 6.74 195 3.59 182 1.65 75.4% 0.0127 45.5% 0.0760
URI 143 4.20 176 4.55 143 4.90 -16.7% 0.7140
AGE 76 2.63 76 2.63 79 0.00 - - 100.0% 0.2388
VAC END 88 7.95 50 10.00 64 3.13 71 0.0 100.0%* 0.0142
SAG 46 0 48 0.00 38 5.26 - 0.1981 68.2% 0.0243
SAL 63 7.94 60 1.67 65 0.00 100.0% 0.0266
T&C: Testing and culling; VAC: Vaccination; HER, URI, AGE, END, SAG, SAL: Herd codes; AI0: Ante-intervention sampling; PI1: First post-
intervention sampling; PI2: Second post-intervention sampling (includes 48 months control for farm END); PI4: Fourth post-intervention sampling 
(corresponds to 60 months post-intervention only for END). Reduction is calculated as the quotient of the difference in proportions to the initial 
proportion. * Herd reduction calculated at the last control for END. p: Fisher exact test probability of the difference being due to chance.
Table 2: Milk production
Dependent variable Strategy Vaccination No. of records Marginal mean (kg) Difference P
T&C Ante-intervention 1040 10374.96 -186.87 0.2318
Post-intervention 242 10288.09 (1.80%)
Standard lactation VAC Ante-intervention 767 9420.51 257.13 0.0379
Post-intervention 364 9677.64 (2.73%)
T&C Ante-intervention 1040 31.55 -0.21 0.7486
Average daily production Post-intervention 232 31.34 (0.67%)
VAC Ante-intervention 767 29.27 1.15 0.0016
Post-intervention 364 30.42 (3.92%)
* First sampling date was set as the ante/post-vaccination threshold.BMC Research Notes 2009, 2:233 http://www.biomedcentral.com/1756-0500/2/233
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nomically efficient strategy at similar or better epidemio-
logic performances with T&C[2]. Since it involves
protecting animals instead of killing the infected ones,
vaccination is also a more sustainable strategy for paratu-
berculosis control than T&C.
Materials and methods
Farm selection
Six Holstein Friesian herds of the Basque Country with a
history of clinical paratuberculosis whose owners were
willing to collaborate were selected. The annual incidence
of paratuberculosis clinical cases in these herds ranged
from 2 to 10%. They were officially free of bovine tuber-
culosis for, at least, the last 5 years as determined by regu-
lar intradermal tuberculin test. The first herd (END) to
enter the study was vaccinated in January 2003 and the
other three (AGE, SAG, SAL) were vaccinated in March
2006. Two herds of similar characteristics were kept as
controls submitted to a test and cull strategy without vac-
cinating any animals. This strategy consisted in recom-
mending the farmers to cull animals with an indirect
ELISA or fecal PCR positive result. The two non-vaccinated
herds were sampled for the first time in May, 2006 and
this date was set as the threshold for intervention tempo-
ral comparisons.
Vaccine administration
One ml of the Silirum® MAP vaccine (CZ Veterinaria, S.A.,
Porriño, Spain), was administered subcutaneously into
the dewlap of all animals of all ages present in the farm at
the moment of joining the trial, and then to all the new 1-
2 month old replacer female calves. This resulted in that
over 80% of the post-vaccination observations were from
animals vaccinated when older than 3 months. Each dose
contained 2.5 mg of heat-killed 316F MAP strain plus an
oil adjuvant and thiomersal as preservative.
Experimental vaccination was carried out according to the
Spanish legislation. It was authorized by the competent
local Animal Health and Animal Experimentation author-
ity (Animal Health Service of the Diputación Foral de
Gipuzkoa and Diputación Foral de Bizkaia, respectively
for the vaccinated and non-vaccinated herds), the Spanish
drug registration authority (Agencia Española de Medica-
mentos y Productos Sanitarios as AEM n° 107/ECV) and
well as by the central Animal Health authority (Spanish
Ministry of Agriculture, Fisheries and Food, currently Min-
isterio de Medio Ambiente y Medio Rural y Marino).
Fecal sampling
Feces were collected from the rectum of the cows older
than 24 months on the ante-intervention (AI0) control at
the time of reading the intradermal test and at yearly inter-
vals afterwards. They were stored at 4°C and processed
within 48 h of arrival to the laboratory for DNA isolation
and for fecal culture.
Amplification of MAP DNA from fecal samples
Isolation of MAP DNA from fecal samples was performed
using the Adiapure MAP DNA extraction and purification
kit (Adiagene, Saint Brieuc, France). Two μl of DNA solu-
tion were tested with a commercial qualitative Real-Time
PCR kit based on the amplification of a segment of the
MAP IS900 sequence (Adiagene, Saint Brieuc, France)
according to the manufacturer instructions. For each set of
reactions, positive (MAP DNA from an ATCC19698 cul-
ture) and negative (no DNA) controls were included. The
amplifications were performed in an ABI Prism type 7000
(Applied Biosystems, Foster City, CA, US) thermal cycler
under the following conditions: 2 min at 50°C, 10 min at
95°C and 45 cycles of 15 s at 95°C and 60 s at 60°C.
Results were read as positive when the reaction showed a
typical amplification curve and a Ct value below 40.
Detection of MAP by fecal culture
Culture of MAP from fecal samples was performed as pre-
viously described [19] on home-made Herrold's Egg Yolk
medium (HEYM) and in Löwenstein-Jensen medium (L-
J) (Difco, Detroit, Michigan, US), both supplemented
with mycobactin J (Allied Monitor, Fayette, Missouri,
US)[20]. Tubes were observed every 4 weeks and consid-
ered negative if after 20 weeks no bacterial growth was
observed. Samples were considered positive if 1 or more
colonies forming units (CFU) were morphologically iden-
tified as MAP in 1 or more culture tubes. Animals were
classified as low shedders (< 10 CFU; estimated average 2
CFU/tube), medium shedders (10 to 50 CFU; estimated
average 20 CFU/tube) and heavy shedders (> 50 CFU; esti-
mated average 200 CFU/tube). Colony identity was con-
firmed by PCR amplification of the IS900 MAP insertion
sequence, as described above.
Milk production
Records of individual cow production kept by the Basque
Federation of Friesian Breeders (EFRIFE) were kindly pro-
vided by M. Eugenia Amenabar. They included date of
birth, date of calving, monthly milk production record,
days of lactation and real and 305 days-standard milk pro-
duction per lactation. The records corresponding to years
2000 to 2007 were used representing up to 5 years before
and after intervention.
Statistical analysis
The frequency of shedders before and after intervention
according the herd strategy (vaccination or test and cull)
were compared using the SAS statistical package Fisher
exact test of the FREQ procedure (SAS Institute Inc., Cary,
NC 27513, USA). A quantitative estimate of overall bacte-
rial contamination by fecal shedding was made according
to the quantitative equivalences defined above for each
level of colony counts. After natural logarithm transfor-
mation the results were submitted to analysis of variance
and least square means comparison with the GLM proce-BMC Research Notes 2009, 2:233 http://www.biomedcentral.com/1756-0500/2/233
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dure taking as independent variables the type of interven-
tion, the time after intervention and their interaction.
For milk production, the SAS GLM procedure was used for
analysis of variance and least square mean comparison of
real lactation, days of lactation, standard 305 days lacta-
tion kg of milk (SL) and average daily production (kg of
milk divided by actual number of days in lactation, ADP)
as dependent variables. In this model, strategy, interven-
tion (ante- and post-intervention date) and parity were
used as independent variables. All the least square means
where compared using the Student's t test with the Tukey
adjustment for multiple pair-wise comparisons.
Reductions and increases were calculated as the quotient
of the difference between the compared and the reference
level mean or frequency to the reference level mean or fre-
quency.
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